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Abstract 
 
One objective of this study was to determine the accuracy of the LeadCare® 
System in testing the lead (Pb) content of post-mortem body fluids in birds.  Birds 
brought to the Tufts Wildlife Clinic that died or were euthanized were frozen then 
thawed before necropsy.  Post-mortem fluid tests were comparable to pre-mortem 
blood samples.  Another objective was to compile the Pb levels of all patients 
tested from 2002-2006.  Elevated Pb levels were detected in species not typically 
associated with Pb exposure. 
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Chapter 1 Background 
 A significant amount of research has been done on the effects of lead on avian species 
around the world.  It has become an important environmental concern not only because lead (Pb) 
is toxic to animals, but also because of the implications lead in the environment has for humans.  
It has been shown that Pb poisoning in children has behavioral side-effects along with possible 
mental retardation over a long period of exposure (Gasana and Chamorro, 2002).   This 
background chapter provides a brief overview of Pb in the environment, the extent of Pb toxicity 
in birds, physiological effects in birds, and various methods of blood Pb testing.   
 
Lead in the Environment 
 Unlike for other toxic materials, no evidence of a mechanism has been noted to date of 
re-absorption of Pb by the environment.  It may react with certain salts to form other Pb 
compounds (De Francisco, Troya, and Aguera, 2003). However, these compounds are then 
ingested by wildlife; they do not disappear from the environment.  In 1990, 3x10
6
 tons of Pb 
were used in production of items such as batteries and cable sheathing (Miller et al., 1990; 
Global Pbnet.org). Although many policies have been put in place in order to phase out the use 
of Pb, particularly from gasoline and house paint, it remains a large public health issue (Gasana 
and Chamorro, 2002). 
 One reason to study animals with Pb poisoning is to be able to identify sites where they 
ingested Pb to locate potential areas of Pb toxicity for humans.  The U.S. Fish and Wildlife 
Service recommend the use of study samples from Pb-poisoned birds and marking their locations 
of origin (Friend, 1985).  In this way problem areas that are identified can be studied more 
thoroughly in order to begin environmental rehabilitation procedures. 
 
Extent of Lead Poisoning in Birds 
 Lead, particularly within the past 20 to 30 years, has been a significant concern among 
veterinarians and conservationists within the bird populations in America.  Many birds are dying 
from Pb toxicity, including taxa not typically associated with having elevated Pb levels such as 
raptors and songbirds.  This is currently not widely recognized as an environmental issue.  Many 
of these birds are not consuming Pb through Pb shot and fishing weights, but through their 
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normal diet. It is estimated that 3,000,000 birds die in America from Pb poisoning every year 
(De Francisco et al., 2003). 
 According to a study completed in western Canada from 1986-96, 10% of the 372 eagles 
tested for Pb had levels high enough to be considered Pb poisoning (Wayland et al., 1998).  Five 
percent more had levels that were elevated.  Of the 10% with Pb poisoning, 28% of the golden 
eagles (Aquila chrysaetos) tested had high (lethal) Pb levels, and 13 % of the bald eagles 
(Haliaeetus leucocephalus) tested had high Pb levels.  These were mainly in adult birds.  Birds 
were collected from wildlife agencies in the area and from raptor rehabilitation organizations 
over the 10 year period.  The authors took blood samples from the birds that were alive, and 
tissue samples from necropsies.   
 A recent study in England identified a high percentage of mute swans (Cygnus Olor) with 
Pb in their body (Perrins, Cousquer, and Waine, 2003).  However, sources of Pb such as fishing 
weights were not found in the bird.  Out of 1276 birds tested, over 60% had elevated Pb levels 
(1.21umol/L[24.85ug/dL]).  This is an enormous percent, and Pb shot or Pb fishing weights 
probably does not account for all of this. 
 
Physiological Effects of Lead  
 There are numerous physiological changes recognized in birds with high Pb levels.  
Burger and Gochfeld (1993) completed an analysis of behavioral side-affects after herring gull 
nestlings (Larus argentatus) were given small doses of lead.  The authors looked for changes in 
behavioral development compared to the control group.  They found that the chicks with Pb in 
their diet tended to not differentiate between individuals as parents and that they also were 
slower to move towards food (Burger & Gochfeld, 1993).  These behavioral symptoms are very 
significant in young birds and could easily lead to the chick’s death in the wild.   
 Other physiological symptoms include problems with normal organ function, severe 
organ damage, and general emaciation and anemia (Mateo et al., 2003).  One organ affected by 
Pb is the gizzard which may not function properly if it contains Pb fishing weights or Pb shot.  
Both the kidneys and the liver can have severe damage due to Pb toxicity.  These organs function 
to filter Pb out of the system.  Emaciation can be caused by a number of factors including 
problems with the digestive tract which leads to less intake of food, and neurological effects 
because the animal has difficulties finding and ingesting food. 
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  Studies have also discovered mechanisms for some of the molecular effects of Pb 
poisoning.  It has been found that Pb inhibits blood δ-aminolevulinic acid dehydratase (ALAD) 
activity while it elevates protoporphyrin (PP) concentration (Henny et al., 1991).  In order to 
sustain levels of hemoglobin in erythrocytes, ALAD is required in the biosynthetic pathway of 
heme (Mamet et al., 2001). Without heme synthesis, due to the inhibition of ALAD, anemia 
develops.  This is a common symptom in Pb poisoning.  By inhibiting the enzyme ALAD, Pb is 
also elevating PP levels because ALAD takes the iron from PP in heme synthesis.  Without 
ALAD activity, PP accumulates in the erythrocyte because there is no feedback mechanism in 
place (Mamet et al. 2001). 
 
Blood Lead Testing 
 Since 1942, lead blood level testing has evolved to be more precise and use smaller 
volumes of blood (Searle et al., 1973).  Today, there are a variety of test methods available with 
which to monitor blood Pb levels in wildlife, including atomic absorption spectroscopy, graphite 
furnace atomic absorption spectrometry, aminolevulinic acid or protoporphyrin blood levels, and 
anodic stripping voltammetry.  These methods vary in price and difficulty of use, as well as in 
their prevalence of use in the veterinary community. 
 Two indirect methods of determining blood Pb concentrations are available.  Exposure to 
Pb causes an increase in the presence of urinary δ-aminolevulinic acid (ALA).  Therefore, after 
being mixed with a number of reagents that separate the ALA molecules from other molecules, 
urine samples can be tested for their absorbency at 553 nm and compared to a standard curve to 
ascertain the Pb concentration.  This method requires 15+ minutes of preparation and procedure, 
as well as access to a spectrophotometer (Tomokuni and Ogata, 1972).  Similarly, because Pb 
exposure increases the concentration of protoporphyrins (PP), the PP concentration can also 
reveal Pb concentration.  However, a 1979 study of Pb poisoned mallards showed that raised PP 
levels could not be determined until two days after the blood had been drawn (Roscoe and 
Nielsen, 1979).  The two-day wait, in addition to the need for a spectrophotometer, suggests that 
testing for PP levels is an impractical method for clinical use. 
 Atomic absorption spectroscopy (AAS) was first introduced in 1955 (Rains, 1969).  Due 
to such characteristics as its high sensitivity and versatility with a number of elements, AAS 
became a major analytical technique in less than 10 years (Lewis, 1969).  In the case of urine 
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tests, AAS was an improvement on an earlier method that utilized colormetric determination and 
was often inaccurate (Willis, 1962).  The AAS method requires converting a sample, such as 
blood or urine, into atomic vapor by use of a flame and then analyzing the resulting vapor for 
light absorbency at a wavelength typical of the element being tested (Walsh, 1969).  These 
wavelengths change according to the materials used, such as the lamp or cathode through which 
the sample travels (Rains, 1969).  In graphite furnace atomic absorption spectrometry (GFAAS), 
the flame used for AAS is replaced with a constant-temperature furnace.  This method eliminates 
the nonuniformities caused by combustion that sometimes interfere with the accuracy of a 
reading (Woodriff et al., 1977). 
 The atomic absorption methods remained the most commonly used until the anodic 
stripping voltammetry (ASV) method was developed. This method was first recommended for 
use with blood and urine in 1970.  Using as little as 50 µl of blood, it works by concentrating the 
Pb ions of a sample onto a carbon electrode and then reversing the current, which strips the Pb 
ions from the electrode and creates a peak current that is proportional to the concentration of Pb 
in the sample (Searle et al., 1973).  The 1973 study by Searle et. al compared determined Pb 
concentrations in blood and urine samples of Pb-poisoned and normal patients using the AAS 
and ASV methods.   Of 224 samples analyzed, the ASV results correlated well with the AAS 
results, with no significant deviation between the two.  Additionally, advantages of ASV over 
AAS were noted, including increased sensitivity and lower cost.  For clinical use, ASV seemed 
to be the more practical method. 
 In 1976, a rapid micromethod was developed for ASV that used hydrochloric acid to lyse 
blood cells, rather than perchloric acid, and it ultimately eliminated a step that could decrease the 
accuracy of the ASV method (Morrell and Gridhar, 1976).  Elimination of this step also made the 
micromethod easier to perform and less time-consuming.  The idea of the micromethod most 
likely became the basis for the development of the LeadCare® Analyzer, a clinical machine for 
testing blood Pb levels. 
 The LeadCare® device, manufactured by Environmental Science Associates (ESA Inc), 
needs only 50 µL of blood to give a reading within three minutes.  It uses anodic stripping 
voltammetry with a hydrochloric acid reagent to determine the concentration of Pb in the sample. 
Results are accurate at a minimum level of 1.6 µg/dl and will give a numerical result for levels 
up to 65 µg/dl.  Levels above that are given only as “high.” (LeadCare® User Manual).  A 2003 
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study compared blood Pb results from blood samples of various wild bird species tested with the 
LeadCare® device and with GFAAS.  Results showed that, compared to GFAAS, the 
LeadCare® analyzer was statistically accurate for purposes of clinical diagnosis (Reinhagen and 
DeNezzo, 2003).  Unlike the ALA, PP, AAS or GFAAS methods, the LeadCare® device is 
practical for use in a clinical laboratory where a diagnosis of Pb toxicity needs to be made as 
soon as possible in order for treatment to begin. 
 Due to its low cost and portability, the LeadCare® device has become a common testing 
method for blood Pb screening not only in pediatric offices, but in veterinary clinics, as well.  
The Wildlife Clinic at the Tufts Cummings School of Veterinary Medicine, the San Diego Zoo, 
and the Falcon Medical Research Hospital in Saudi Arabia, are three examples of veterinary 
clinics that employ this device.  Daily medical care at these facilities has included frequent blood 
level testing of avian species.   
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Chapter 2 Project Description 
 There were two primary objectives for this project:  to determine the ability of the 
LeadCare® device to detect lead in post-mortem body fluids and to analyze archival data for 
trends in patients from the Tufts Wildlife Clinic tested positive for lead.  Each objective had 
several goals: 
• Detecting Lead in Post-Mortem Fluids 
o Test for the effect of shelf or refrigeration storage on blood and fluid samples, 
before and after being mixed with the LeadCare® reagent. 
o Test pre-mortem blood samples for lead concentration using the LeadCare® 
device. 
o Obtain and test post-mortem fluids for presence of lead. 
o Compare test results of pre- and post-mortem samples. 
• Analyzing Archival Lead Test Results 
o Compile four years of patient and lead test data into a spreadsheet. 
o Display locations of the origins of patients that tested positive on a map. 
The methods used to complete these objectives and achieve the goals are explained in detail in 
the next chapter. 
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Chapter 3 Methods 
 The experimental methods we used for our study are described in this chapter.  Protocols 
include those for obtaining fresh blood samples and post-mortem body fluids, for determining 
the effects of storage on samples, and for developing an archival analysis with a geographic 
distribution.  Additionally, a total of nine blood samples were used to test for storage accuracy.  
Seven post-mortem fluid samples taken from birds were tested for Pb content.  There were 302 
patients who had been tested for Pb since 2002 with files available for analysis.   
 
Blood Pb Testing 
Peripheral venous blood samples were taken from live animals through a vein and were 
placed in lithium heparin tubes.  Less than 1mL was taken from each animal.  Blood was drawn 
from all animals to be euthanized including species other than birds.  Using the provided 50µL 
pipette and 200µL pipette tips, 50µL of the sample was taken from the heparin tube and placed in 
the LeadCare® reagent tube. (This amount needed to be precise in order to obtain an accurate 
reading.) The mixture was swirled in the reagent tube in order to thoroughly mix. The sample 
was allowed to sit for 2 to 3 minutes in order to complete the acid reaction.  According to the 
LeadCare®  manual, the reagent tube could then be placed in the fridge for up to seven days 
before testing or it could be tested at that time.  When ready to test, 50µL of the mixture from the 
reagent tube was placed in the well on the LeadCare® sensor strip.  The machine took three 
minutes to read the sample. Readings were given in micrograms per deciliter (µg/dL).  Each 
result was recorded along with the date, patient species, patient ID, and who tested the sample.  
For more detailed instructions written specifically for use of the LeadCare® device, please see 
Appendix D. 
 
Effects of Storage on Accuracy of Samples 
The project schedule did not allow for constant vigilance over blood samples taken from 
subjects.  For this reason, the effects of various storage methods were tested for their accuracy.  
A set of nine pre-mortem samples (already mixed with heparin to prevent clotting) were tested 
for lead concentration immediately after the blood was drawn, and after 2-7 days in the 
refrigerator, with and without having been mixed with the reagent before being placed in the 
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refrigerator.  Samples were also tested for accuracy without being placed in a refrigerator, to 
determine how long samples could sit at room temperature and still yield accurate results. 
 
Obtaining Post-Mortem Fluids 
 Post-mortem cadavers were frozen at -20°F and then thawed at room temperature for 3-5 
days to allow fluids to collect in the body cavity.  Birds were then dissected according to a 
standard avian necropsy protocol.  The bird was placed in a prone position on the exam table, 
wings pulled back, exposing the ventral tract.  Using a surgical scalpel, an incision was made 
along the sternum.  The layers of skin and muscle were separated and peeled away from the 
sternum.  The sternum was removed in order to access the organs beneath it.  Once the body 
cavity was opened, attempts were made to collect body fluids to test for Pb concentration.  
Photographs of open cavities were taken and labeled according to the location where fluid was 
found and/or for which it was searched.  These pictures can be found in Appendix B.  Fluids 
were mainly found cranial to the liver and around the heart or below the organs in the dorsal area 
of the body cavity after opening.  These fluids were tested using the same protocol for blood 
samples above. 
 
Archival Analysis  
 Since the purchase of the LeadCare®System in 2002 by Tufts Wildlife Clinic, over 300 
blood samples from various species of animals have been tested for lead. The records kept 
included the patient species, patient ID, date tested, and test results.  These were all placed into a 
spreadsheet.  Along with all data we also examined the patient records and recorded the locations 
where each animal was found and any symptoms the patient exhibited upon arrival.  This 
information is located in Appendix C.   
 
Map Creation 
In order to display specific geographic origins of patients that tested positive for Pb, we 
used Google Earth ©.  This free program allowed us to search global satellite imagery for 
specific locations, and then place and display customized markers as data points. 
Maps were constructed using geographic origins as recorded in patient files as data points.  
Origins were organized into folders by Pb level.  For example, all results between 0 and 1.4 
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µg/dl were in one folder because these data points were potentially inaccurate.  Next, all results 
from 1.41 to 9.9 were combined into one folder and could be displayed together and separately 
from the other data groups.  Remaining folders were classified as 10 – 19.9, 20 – 29.9, 30 – 39.9, 
40 – 49.9, 50 – 59.9, and > 60 µg/dl.  The last folder included any result that registered as “HI.”   
The town of origin was entered as “XXXX, MA” unless the patient was brought to the 
clinic from a different state.  Most records did not have origins more specific than the town.  
Subsequently, markers could not be placed on particular roads or bodies of water.  The marker 
was placed at the point the program chose for the city.  If more than one marker was at the same 
location in the same folder, one of them would be shifted slightly to avoid overlap.  Therefore, 
the position of the data marker only corresponds to the town of origin.  Markers were also 
colored to distinguish levels from each other when displaying more than one folder at a time. 
Once the folders had been created, they were displayed by clicking the check mark on 
and off in the box next to the folder.  All of the folders could be displayed simultaneously, or one 
could be displayed independently without interference from the others. 
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Chapter 4 Results 
 This chapter presents the results of all experiments and analysis done in this study.  The 
effects of storage on sample accuracy, the comparison of accuracy between pre- and post-
mortem samples, and the collective data from the archival analysis are included. The results of 
the retrospective study contain the distribution of Pb levels, species, symptoms, and geographic 
origins of the patients. 
I. Pre-mortem vs. Post-mortem 
Storage Accuracy of LeadCare® Reagent 
 The first study completed involved the testing of the storage accuracy of the mixed 
reagent from the LeadCare® system.  Refer to Methods for a description of mixing procedure.  
Nine samples were tested the day they were mixed and then saved and re-tested 6-7 days later.  
The results are located in Table 4.1 below. 
 
Table 4.1: Storage accuracy of Pb mixed blood samples 
Test 
Sample 
Pb Result 1
st
 
Test (µg/dL) 
Pb Result 2
nd
 
Test (µg/dL) 
Difference 
(ug/dL) 
Fridge length 
(days) 
1 6.5 5.2 -1.3 7 
2 34.8 33.6 -1.2 7 
3 14.8 13.4 -0.9 7 
4 24.0 25.2 1.2 6 
5 7.8 5.7 -2.1 6 
6 7.3 8.1 0.8 7 
7 2.8 2.2 -0.6 7 
8 3.1 2.6 -0.5 7 
9 6.1 7.0 0.9 7 
  Average 
Difference 
-0.4  
  Standard 
Deviation (σ) 
±1.2  
 
 The average difference from 0 days to 7 days in the fridge was -0.4 µg/dL.  Three out of 9 
samples increased with an average of 1.0 µg/dL. Six out of 9 samples decreased with an average 
of -1.1µg/dL.  The LeadCare® system claims the machine has a variability of ±3.0µg/dL.  
Therefore, the effects of lengthier storage times on sample results proved to be insignificant in 
terms of true differences in values.  The standard deviation of ±1.2 µg/dL falls well within this 
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range.  A more detailed chart of original data is located in Appendix A.1.  Figure 4.1 
demonstrates a graphical representation of the differences in sample tests.  The dashed line 
represents the first test and the solid line shows the value of the second test.  There is almost no 
difference between the two. 
 
Storage Accuracy Test Results
1
2
3
4
5 6
7 8
9
0
5
10
15
20
25
30
35
40
Test Sample Number
Pb Level 
(ug/dL)
1st Test Level 2nd Test Level
 
Figure 4.1. Storage accuracy results 
 
Pre-mortem vs. Post-mortem Results 
 One of the main goals of this study was to examine the suitability of the LeadCare® test 
for analyzing post-mortem avian body fluids.  Throughout our 4 month study, 13 cadavers were 
saved, however, only 7 samples were able to make it to the point of extracting post-mortem body 
fluids.  The 7 samples received are detailed in Table 4.2, including both pre and post-mortem 
values.  More detailed information is located in Appendix A.3. 
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Table 4.2. Results of pre and post-mortem Pb testing 
Sample 
Number 
Pre Pb Level 
(ug/dL) 
Post Pb Level 
(ug/dL) 
1 65 65 
2 3 5.7 
3 9.2 4.7 
4 30 9.4 
5 9.4 10 
6 5.8 4.7 
7 1.5 2 
 
 Figure 4.2 below is a graphical representation of the pre and post mortem Pb test results 
of each individual.  The pre-mortem blood Pb level is represented by the solid line, and the post-
mortem body fluid Pb level is represented by the dashed line.  In many of the samples the 
difference was very small. 
 
Pre vs. Post-Mortem Pb Levels
1
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Pre-mortem Pb Level Post-mortem Pb Level
 
Figure 4.2. Pre and post mortem results 
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 The average difference from pre to post-mortem samples was -3.2µg/dL.  The standard 
deviation of the difference between pre and post-mortem Pb levels of the seven samples was 
±8.0µg/dL.  This high value was due to one outlier.  The standard deviation without the outlier 
was ±2.4µg/dL.  This data along with deviations is located in Table 4.3. 
 
Table 4.3. Standard deviations of differences between pre and post-mortem test results 
Patient Number Difference 
(pre-post, 
ug/dL) 
Deviation from σ1 Deviation from σ2 
1 0 8.0 2.4 
2 2.7 5.3 0.3 
3 -4.5 3.5 2.1 
4 -20.6 12.6 -* 
5 0.6 7.4 1.8 
6 -1.1 6.9 1.3 
7 0.5 7.5 1.9 
Average difference: -3.2   
Standard deviation of 
all 7 (σ1):  
±8.0   
Standard deviation 
w/out 4 (σ2): 
±2.4   
                 *Note: This sample was inaccurate and the fluid obtained contained bile from the digestive system. 
 
II. Retrospective Analyses 
 An analysis of all previous Pb tests recorded at the clinic was completed.  This 
encompassed all tests since the purchase of the test kit in 2002.  A number of items were 
analyzed including: 
• Animal tested (i.e. aquatics, raptors) 
o Species tested (i.e. Canada goose, Common loon) 
• Blood Pb result distribution 
• Geographic location of animal tested 
o Different severities of Pb levels at different locations 
• Symptoms of animal tested 
 
Type of Animal Tested 
 A total of 302 animals have been tested for Pb at the Wildlife Clinic since 2002.  Of these, 
52.6% were aquatic birds with a total of 159 tested.  Raptors such as hawks and falcons formed 
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16.9% of the animals tested.  Pigeons, doves, and other birds, comprised 15.9% of the animals 
tested. These values are represented in Figure 4.3 below and can be located in Appendix C.2.  
There were also a number of other species of animals such as a raccoon and a llama.  A complete 
list of species tested can be found in Appendices C.7.   
 
Distribution of Animals Tested for Lead
0
20
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100
120
140
160
180
Aquatics Hawks/Raptors Other Birds Other Animals
Category
Number
Tested
 
Figure 4.3. Bar graph of taxa distribution of animals tested for Pb 
 
Blood Test Result Distribution 
 The variation in the distribution of the Pb level of the animals tested was also examined.  
As can be seen in Figure 4.4, most (68.9%) fell below the 10.0µg/dL range.  This 10.0 µg/dL  
value is important to note because this is the level at which humans are treated for Pb toxicity.  A 
large percentage fell above that range at 31.1%.  Below 10.0µg/dL, the levels were split into two 
sets.  This was done because the LeadCare® System is not accurate below 1.4µg/dL.  Therefore, 
we assumed those tests were not accurate and the actual Pb level was impossible to determine at 
such low values.   
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Lead Levels of Animals Tested
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Figure 4.4. Distribution of Pb levels of all animals tested 
 
 Most animals with Pb levels at or above 20.0µg/dL at the Wildlife Clinic are given 
chelation treatment.  Of all animals tested for Pb toxicity at the clinic, 19.5% were above this 
clinical cutoff. This cutoff is noted in the chart (Fig. 4.4) as a dashed line. This 19.5% value 
included 59 animals in the past four years at the clinic that had been tested for Pb toxicity.  The 
data for this chart are located in Appendix C.1. 
 
Aquatics Distribution 
 Each group of animals was examined in more detail to show a distribution of their Pb 
levels.  Most of the groups had the majority of animals tested with Pb levels below 10.0µg/dL.  
The second highest was usually a reading of “HI”.  In this case, the students or veterinarians 
accurately diagnosed the symptoms of the animal as lead poisoning. 
 Of waterfowl tested, 63.7% had Pb levels below 10.0µg/dL.  There was also a high 
percentage (21.4%) over 20.0µg/dL.  The percentage with “HI” levels was 9.4%.  A graphic 
display of these data is located in Figure 4.5.  The original data can be found in Appendix C.3.   
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Figure 4.5. Distribution of test results of aquatic bird species 
 
Hawks/Raptors Distribution 
 Of hawks tested, 74.5% had Pb levels below 10.0µg/dL.  There was a much lower 
percentage (5.9%) of birds with levels over 20.0µg/dL with only one bird having a level over 
50.0µg/dL and none with “HI” levels.  A graphical display of this data is located in Figure 4.6.  
The original data can be found in Appendix C.4.   
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Figure 4.6. Distribution of test results of land predators 
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Other Birds Distribution 
 Only 45.8% of other land birds tested had Pb levels below 10.0µg/dL.  A much higher 
percentage, 41.7%, had levels above 20.0µg/dL.  A graphical display of this data is located in 
Figure 4.7.  The original data can be found in Appendix C.5.   
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Figure 4.7 Distribution of test results of other birds 
 
Other Animal Species Distribution 
 Out of the 33 other animal species tested, only 2 had levels above 10.0µg/dL.  However, 
48.8% of patients tested had positive tests, meaning their blood Pb level was above 1.4µg/dL.  
This demonstrates that some Pb did exist in their bodies.  A graphical display of this data is 
located in Figure 4.8.  The original data can be found in Appendix C.6.   
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Figure 4.8. Distribution of test results for other animal species 
 
Retrospective Patient Outcome 
 Out of 188 patients with available results, less than half lived to be transferred or released.  
Only 11.7% died in house, but 46.3% were euthanized while in the hospital.  Patient results 
include animals with all levels of Pb intoxication, but the majority of which had levels lowers 
than 20 µg/dL.  Figure 4.9 below displays patient results in bar graph form.  Figure 4.10 is more 
specific, breaking results down by Pb level range. 
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Figure 4.9. General outcome of patients tested for Pb 
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Figure 4.10. Outcome of patients tested for Pb according to level 
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Patient Origins 
 Records showed that there were 91 different origin points for patients.  These points were 
towns or cities within Massachusetts.  Only 39 of these points (43%) were origins for more than 
1 patient.  Points with significant numbers of patients were Boston with 6, Westboro with 5 and 
Worcester with 17.  The remaining 36 points had from 2 - 4 patients.  The map below (Fig. 4.11) 
shows the geographic range of origins with >1 patient.  The point farthest west is Springfield, 
MA, and the farthest southeast is West Barnstable, MA.  Labels for the three cities are positioned 
just directly to the right of their origin.  A cross indicates a point of origin for two or more 
patients. 
 
 
Figure 4.11. Map of origins with >2 patients 
 
 When all of the origins are viewed, the geographic range extends as far south as 
Nantucket.  However, the majority of all patients originated from an area between Boston and 
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Worcester, as can be seen in Figure 4.12 below.  In Figure 4.12, a dark cross indicates a point of 
origin for one or more patients. 
 
 
Figure 4.12. Map of all origins of patients 
 
Patient Symptoms 
 Of all of the available files, 189 listed symptoms of the patients.  The symptoms 
diagnosed for each patient were placed into one of five categories:  
• Emaciation and/or dehydration 
• Fractures, wounds, and/or trauma 
• Depression (including quietness or an inability to stand or fly) 
• Neurological (such as tremors) 
• The presence of lead objects (such as fishing gear or shot)  
Most patients had more than one of these symptoms.  Very few exhibited no symptoms.  
Emaciation and/or dehydration and fractures, etc., were the two most commonly found 
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symptoms, with 51% and 48% of patients exhibiting such symptoms respectively.  The third 
most common symptom, depression, was observed about half as often in only 23% of patients.  
Much less frequently observed were neurological symptoms (6%) and the presence of Pb objects 
(4%).  Figure 4.13 displays these results. 
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Figure 4.13.  Distribution of symptoms in patients tested for Pb toxicity 
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Chapter 5 Discussion  
 The LeadCare® System is the one used by Tufts Wildlife clinic for their tests.  This test 
is meant for use with children, however it has been proven accurate in avian Pb testing by 
Reinhagen & DeNezzo (2003).  They compared results between the LeadCare® System and the 
graphite furnace atomic absorption spectrophotometry method and found the two methods to be 
statistically equal.  Therefore this system was deemed accurate and appropriate for other 
experimentation.  This project studied the limitations of the LeadCare® System in testing of 
body fluids as opposed to blood samples.  
I. Pre-mortem vs. Post-mortem 
 Due to time limitations, samples needed to be saved for testing up to a week after they 
were taken.  Therefore storage accuracy was tested before the pre to post-mortem testing could 
begin. 
 
Storage Accuracy of LeadCare® Reagent  
 Through this accuracy experiment, it was determined that the LeadCare® Manual 
recommendations were correct saving blood samples from birds.  This was equivalent to less 
than 24 hours of blood sitting at room temperature in heparin tubes, mixed with the reagent and 
sitting at room temperature for less than 48 hours after this, or mixed with the reagent and placed 
in the refrigerator for up to 7 days.  Every test completed fell within the accuracy range of the 
machine (±3.0µg/dL).     
 
Pre-mortem vs. post-mortem  
 According to the statistical tests completed, the LeadCare® Test was accurate in 
determining post-mortem body fluid levels in avian species.  There was one outlier, Test #4, that 
was far outside of the ±3.0µg/dL range of the test.  This was due to a difficulty in receiving fluids 
from the body.  In attempting to obtain body fluids, bile was taken with other general fluid and 
therefore this did not give an accurate reading of the Pb level in the bird.  Without this outlier, 
the standard deviation from the average was ±2.4µg/dL, which is within the accuracy range of 
the machine.   
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 In the clinic, an animal with a Pb level above 20.0ug/dL is usually diagnosed as having 
lead toxicity and subsequently undergoes chelation treatment.  In the tests, only the outlier 
described above would have changed the classification of the bird’s Pb level from when it was 
alive to after death.  All of the other tests remained in the same category as noted in the charts 
(i.e. 1.4 to 9.9µg/dL, 10 to 19.9µg/dL, etc.).  Also, none of the other tests switched from a 
classification requiring treatment (above 20.0µg/dL) to a level lower than 20.0µg/dL and not 
requiring treatment. 
 This demonstrates that this Pb test can accurately be used in the field to test deceased 
birds for Pb levels in their body.  A value obtained would be an accurate estimate of the Pb level 
of the bird in its blood before it died.  Potential implications of this include the ability to 
determine environmental areas of concern for high Pb levels.   
 Future work with this project can include a field study of those birds obtained by the 
Seabird Ecological Assessment Network (SEANET) in Massachusetts and brought to the clinic 
for post-mortem analysis.  SEANET notes the location the bird was found, and therefore a 
determination of Pb levels in the environment in that location can be inferred.  A potential 
further study would involve testing the soil Pb content in the area.   
 By analyzing pre vs. post-mortem Pb levels in birds we were able to determine the 
accuracy of the LeadCare® Test with body fluids as opposed to blood.  Now that this accuracy 
has been determined, this can be used on a broader scale in testing and conducting a solely post-
mortem analysis.  Results from these tests can then be used to determine areas of environmental 
Pb concern in the country. 
II. Retrospective Analyses 
 There were limitations on the retrospective study of patients who were tested for Pb.  Our 
results were based only on the charts that were archived at the wildlife clinic, and so we did not 
have data for patients who had their blood tested but who were being treated at other facilities.  
Furthermore, we did not have complete results for every patient due to missing information in 
the chart such as location of origin and symptoms.   
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Type of Animal Tested 
 Throughout our analysis of the different species of animals tested for Pb toxicity, it was 
very interesting to note the variety of species that had positive results (>1.4ug/dL).  It was also 
interesting to note the variety that tested above a level of 10.0ug/dL (the treatment cutoff in 
humans).  There were also a number of hawks that had Pb levels above 10.0ug/dL including bald 
eagles, red-tailed hawks, turkey vultures, among others.  Those tested with a “HI” Pb level 
included a squirrel, a great horned owl, pigeons, geese, swans, American crow, loons, and a 
gannet. Although many of these are waterfowl and had this high level due to ingested lead shot 
or lead fishing weights, the others had not.   
 From this, questions can be raised as to where these animals are ingesting Pb, and why 
they are ingesting a large amount.  Is there an environmental sink for Pb in Massachusetts from 
remnants of the leaded gasoline era, or is this a new issue that needs to be addressed? 
 These are important discussions that need to be addressed in Massachusetts and around 
the country.  If Pb is clearly being ingested by animals in the environment, then that same Pb 
could pose a threat to humans.   
 
Blood Test Result Distribution 
 Along with the wide distribution of species tested positive for Pb, there was a high 
percentage of those who tested above 10.0ug/dL.  A total of 31.1% of all animals tested at the 
wildlife clinic were at a level that would require treatment in humans, particularly children.  A 
note of interest is that not all of these animals were tested because they exhibited symptoms of 
Pb toxicity.  Some were tested for various research projects, as a last resort for a possible cause 
of the symptoms health decline, or as one of the many blood tests that are completed in a 
thorough analysis of a patient when it arrives.   
 According to the Wildlife Clinic’s standards 19.5% of the patients were at a clinical Pb 
toxicosis level and were then eligible for treatment as being above 20.0ug/dL.  This is also a very 
high percentage and demonstrates a clear problem of Pb in Massachusetts. 
 
Patient Outcome  
 The results of patient outcomes (died, euthanized, lived) were used to make conclusions 
about survival rates for patients that were tested for Pb levels.  We estimate that the clinic 
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survival rate (42%) of these patients is comparable to the overall survival rate for all patients 
treated at the clinic.  However, amongst the patients whose results were in the higher brackets 
(40 µg/dl and up) only 27.7% of patients survived and were relocated or released.  In these 
categories, there is also an increase in the percentage of animals that died in house before they 
could be treated or given euthanasia, from 11.7% to 38.8%.  Therefore, the patients with higher 
levels of lead toxicity had a reduced survival rate as compared to those with lower levels.  We 
anticipate that a larger survey of Pb toxicity in wildlife would give similar results. 
 
Patient Origins 
 There were very few locations (cities or towns) that were the origin for more than 4 
patients.  Of the three, Worcester (17 patients) and Boston (6) are considered to be major urban 
areas.  Westboro (5) is a suburban area.  Both Worcester and Westboro are located in close 
proximity to the clinic, so it’s possible that more patients did not come in from more distant areas, 
like Boston, because they were treated at other locations.  Nonetheless, the origins of Pb tested 
patients span a wide geographical range.  Lead toxicity, therefore, is not confined to one specific 
location or type of location.  Sources of lead vary.  For instance, it can be from highway runoff 
or fishing gear, hence why it is possible for an animal to become toxic in urban, suburban and 
rural areas.  The majority of patients were brought in from the area between Worcester and 
Boston, which also agrees with the possibility that people are bringing animals in for treatment 
because they live close to the clinic. This area of Massachusetts is also varied in terrain, but 
contains many small lakes and rivers where waterfowl are likely to live and people are likely to 
fish or hunt. 
 
Patient Symptoms 
 Patient files were reviewed for the symptoms that accompanied patients who were tested 
for Pb levels.  Unexpectedly, fishing gear and lead shot were found in only 4% of patients.  This 
indicates that lead poisoned wildlife are getting lead from other sources besides solid lead objects.  
In fact, lead objects were found in more patients with lower lead levels (< 10) than the higher 
levels.  (Yet, this could also be due to the much greater proportion of cases on file between 1.5 
and 9.9 µg/dl.)  Overall, the most common symptom was emaciation and/or dehydration, 
followed by some type of wound, fracture and/or trauma.  At 6%, very few patients also showed 
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neurologic symptoms, the effect that it most frequently associated with lead toxicity.  Depression 
was the third most common symptom at 23%.  Combinations of these symptoms may be an 
indicator of the presence of lead in a patient, although a few patients exhibited no symptoms at 
all, meaning that there is no exact formula for determining if a patient should be tested for lead 
poisoning. 
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Appendix A: Storage and Post-mortem Data 
Table A.1. Storage Accuracy – Original Data 
Date Patient Name Patient ID 
Number 
Test 
Results 
Difference Fridge length 
9/1/2006 Herring Gull W061061 6.5ug/dL  5 days 
9/3/2006 " " 5.2ug/dL -1.3 7 days 
8/31/2006 Turkey Vulture W061084 34.8ug/dL    
9/6/2006 " " 33.6ug/dL -1.2 7 days 
9/7/2006 " " 14.8ug/dL  New sample - chelated 
9/12/2006 " " 13.4ug/dL -0.9 7 days 
9/12/2006 Rock Dove W061124 24ug/dL    
9/18/2006 " " 25.2ug/dL 1.2 6 days 
9/16/2006 Red-tailed Hawk W061183 7.8ug/dL    
9/22/2006 " " 5.7ug/dL -2.1 6 days 
9/18/2006 Snapper W061186 7.3ug/dL    
9/24/2006 " " 8.1ug/dL 0.8 7 days 
9/18/2006 Pigeon W061180 2.8ug/dL    
9/24/2006 " " 2.2ug/dL -0.6 7 days 
9/20/2006 Rock Dove W061124 3.1ug/dL   
9/27/2006 " " 2.6ug/dL -0.5 7 days 
9/22/2006 Herring Gull W061210 6.1ug/dL    
9/29/2006 " " 7.0 ug/dL 0.9 7 days 
 
Table A.2. Storage Accuracy Standard Deviation Difference 
Table 3.2.  The difference from the standard deviation. 
Average 
Difference 
-0.4 
Standard 
Deviation 
(σ) 
1.2 
Sample Deviation from 
σ 
1 0.1 
2 0.0 
3 0.3 
4 0.0 
5 0.9 
6 0.4 
7 0.6 
8 0.7 
9 0.3 
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Table A.3. Pre-Post mortem results – Original Data 
Date Patient Name Patient ID 
Number 
Test 
Results 
(ug/dL) 
Pre/Post Other 
Information 
11/5/2006 Mute Swan W061353 HI Pre  
11/10/2006 " " HI Post 
Tested twice, 
once gizzard, 
once liver 
11/21/2006 Canada Goose W061372 3 Pre  
11/29/2006 " " 5.7 Post  
11/21/2006 
Ring-necked 
Pheasant 
W061379 11.2 Pre  
11/28/2006 " " 9.2 Post  
12/5/2006 " " 2.7 Pre 1st sample 
12/5/2006 " " 4.7 Post 2nd sample 
1/17/2006 Mallard W061411 30 Pre 
Blood pulled 
12/18/06 and in 
fridge un-mixed 
1/24/2006 " " 9.4 Post 
Sample contained 
bile, not accurate 
1/24/2007 American Crow #1 W060025 9.4 Pre   
1/31/2007 " " 10 Post   
1/24/2007 American Crow #2 W060023 5.8 Pre   
1/31/2007 " " 4.7 Post  1st time 
1/31/2007 " " 4.6 Post 2nd time 
1/24/2007 Barred Owl W060029 1.5 Pre   
1/31/2007 " " 2 Post   
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Table A.4. Differences and Standard Deviations with pre-post mortem 
results 
Patient Number Difference (pre-
post): ug/dL 
1 0 
2 2.7 
3 -4.5 
4 -20.6 
5 0.6 
6 -1.1 
7 0.5 
Average 
difference: -3.2 
Standard 
deviation of all 7 
(σ1):  7.98 
Standard 
deviation w/out 4 
(σ2): 2.40 
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Appendix B: Photographs of Necropsies 
Figure B.1. Mute Swan W061353 
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Figure B.2. Canada Goose W061372 
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Figure B.3. Mallard  W061411 
 
Figure B.4. American Crow W070025 
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Figure B.5. American Crow W070023 
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Figure B.6. Barred Owl W070029 
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Appendix C: Archival Analyses 
Table C.1. Total distribution of all animals tested for lead since 2002 
Pb 
Level 
Number 
Tested 
0-1.4 77 
1.41-9.9 131 
10-19.9 35 
20-29.9 9 
30-39.9 11 
40-49.9 5 
50-59.9 5 
>60 29 
Total: 302 
 
Table C.2. Distribution of type of animal tested 
Category Totals 
Aquatics 159 
Raptors 62 
Other Birds 48 
Other Animals 33 
Total: 302 
 
Table C.3. Aquatics distribution 
Aquatics:  
Pb Level 
(ug/dL) # Tested 
0-1.4 32 
1.41-9.9 75 
10-19.9 18 
20-29.9 6 
30-39.9 9 
40-49.9 3 
50-59.9 1 
>60 15 
Total: 159 
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Table C.4. Raptor distribution 
Raptors:  
Pb Level 
(ug/dL) # Tested 
0-1.4 14 
1.41-9.9 24 
10-19.9 10 
20-29.9 1 
30-39.9 1 
40-49.9 0 
50-59.9 1 
>60 0 
Total 51 
 
Table C.5. Other bird distribution 
Other Birds:  
Pb Level 
(ug/dL) # Tested 
0-1.4 10 
1.41-9.9 12 
10-19.9 6 
20-29.9 2 
30-39.9 1 
40-49.9 2 
50-59.9 3 
>60 12 
Total 48 
 
 41
Table C.6. Other animal distribution 
Other 
Animals:  
Pb Level 
(ug/dL) # Tested 
0-1.4 15 
1.41-9.9 16 
10-19.9 1 
20-29.9 0 
30-39.9 0 
40-49.9 0 
50-59.9 0 
>60 1 
Total 33 
 
Table C.7. List of animal species tested (Common names) 
Species Key 
Aquatics Hawks/Raptors Other Birds Other Animals 
Canada Goose Peregrine Mourning Dove Snapping Turtle 
Mallard Red-tailed Hawk Raven Squirrel, Gray 
Domestic Duck Red-shouldered Hawk Crow, American Gray Fox 
Swan Bald Eagle Turkey Porcupine 
Herring Gull Golden Eagle Pigeon Llama 
Common Loon Condor, Andean Ring-necked Pheasant Canine 
Gannet, Northern Turkey Vulture Dove Canada Lynx 
Greater Black-backed Gull Broad-winged Hawk Night Hawk Fisher  
Ring-billed Gull Osprey Himalayan Monal Cottontail Rabbit 
Muskovy Goshawk Racing Pigeon Bobcat 
Great Blue Heron Cooper's Hawk Flicker Raccoon 
Roseate Tern Barbary Falcon Wood Pecker Other* 
Common Merganser Sharp-shinned Hawk     
Double-crested Cormorant Great Horned Owl   
Black Scoter Barred Owl     
Eider, Common Screech Owl     
Black Duck       
Laughing Gull       
Other*       
* The “other” in these categories denotes that in the write-up of the Pb result, either the location 
that the bird came from (i.e. SEANET) or a client name from the hospital (i.e. “Fluffy” 
McCullough) was used.  These names are descriptive enough in order to place the animal into 
the broader species category, but not specific enough to place them in a species category. 
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Table C.8. List of all origin locations from Pb tests (only Massachusetts) 
Andover 
Arlington 
Ashland 
Attleboro 
Auburn 
Ayer 
Bedford 
Bellingham 
Billerica 
Blackstone 
Bolton 
Boylston 
Brockton 
Brookline 
Burlington 
Byfield 
Cape Cod Wildlife 
Center (W. 
Barnstable)  
Centerville 
Charlton 
Cherry Valley 
Cochituate 
Dartmouth 
Dedham 
Dorchester 
Fitchburg 
Framingham 
Gloucester 
Grafton 
Hatfield 
Holliston 
Hubbardston 
Hyde Park 
Lancaster 
Leicester  
Lincoln 
Littleton 
Lowell 
Manchester 
Mansfield 
Marblehead 
Marion 
Marlboro 
Marshfield 
Maynard 
Medfield 
Medway 
Melrose 
Methuen 
Millbury 
Milford 
Nahant 
Nantucket 
Natick  
New Marlboro 
Newton 
North Attleboro 
North Grafton 
Norton 
Peabody 
Plainville 
Princeton 
Providence 
Quincy 
Revere 
Rowley 
Roxbury 
Rutland 
Salem 
Salisbury 
Sharon 
Shrewsbury  
Spencer 
Springfield 
Sterling 
Sturbridge 
Sudbury 
Swampscott 
Tewksbury 
Uxbridge 
Wakefield 
Walpole 
Waltham 
Watertown 
Webster 
Wellfleet 
West Boylston 
Westboro 
Winthrop 
Woburn  
Worcester 
Wrentham 
 
Table C.9. Original counts of patient outcomes 
Range # Dead # Euthanized # Lived   
0 - 1.4 6 17 18   
1.5 - 9.9 8 47 38   
10 - 19.9 1 12 10   
20 - 29.9 0 3 5   
30 - 39.9 0 2 3   
40 - 49.9 2 1 1   
50 - 59.9 1 2 2   
60 + 4 3 2   
total 22 87 79 188 
  11.70% 46.30% 42%   
 
Table C.10. Original count of symptoms 
Symptoms Emaciation/ 
dehydration 
Fractures/ 
wounds/trauma 
Depression Neurologic Fishing 
gear/ Pb 
shot 
Percentage 
of Patients 51 48 23 6 4 
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Appendix D: LeadCare® System Manual 
Retrieved from online manual at: http://www.woongbee.com/POCT/leadcare.htm 
 
LeadCare
®
 Childhood Blood Lead Testing 
 
The LeadCare System is for the determination of lead in whole blood. 
When you test young patients for lead levels, you want fast, accurate, 
inexpensive results. You want the LeadCare system, a simple, foolproof 
way to perform blood lead measurements using a finger stick or venous 
sample. No more waiting days for expensive lab analyses. You get 
quantitative blood lead results equivalent to those reported by outside 
laboratories in just three minutes. 
A LeadCare system analysis costs far less than you'd pay an outside 
laboratory, and it qualifies for reimbursement as a quantitative blood lead. 
You'll also cut your staff's result-tracking and administrative time. You'll 
save your patients days of possibly needless worry plus the time-
consuming inconvenience and cost of a return visit. Blood lead 
measurement couldn't be easier. 
LeadCare is easy and safe to use. The hand-held analyzer is portable 
and requires neither manual calibration nor refrigeration. Its unique gold 
electrode sensor contains no mercury or other toxic materials. The point-
of-care LeadCare system was developed by ESA and Andcare with a 
grant from the CDC. It's the diagnostic tool which makes sense medically 
and economically.  
  
  Fast! Easy as 1- 2- 3  
STEP ONE 
 
Draw a capillary or venous blood sample using EDTA or 
heparin as anticoagulants. 
STEP TWO 
 
Using the pipette provided with the kit, dispense 50 µl, about 
two drops of blood, into the reagent and mix. 
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STEP THREE 
 
Transfer it to the sensor strip. Press the button. Just three 
minutes later, you have your result.  
Accuracy 
LeadCare System vs. Atomic Absorption Spectroscopy performed at a major lead outreach and 
referral clinic/hospital 
Number of Samples: 112 
Slope: 1.07 
Intercept: -0.57 µg/dl 
Correlation coefficient: 0.97  
Portable 
Power source: 9V battery or AC adapter  
Dimensions: 7.7 in x 4.2 in x 2.5 in. (19.6cm x 10.7cm x 6.4cm) 
Weight: 14 oz 
Specification 
Test method:   Electrochemical with disposable sensors 
Blood lead level range: 1.4 - 65 µg/dl 
Blood sample volume: 50 µl 
Test time: 3 minutes 
Calibration: Electronic calibration button  
Classification: Moderately complex under CLIA guidelines. Suitable for use in physician's office 
laboratory. 
  
  
Theory of Anodic Strippimg Voltammetry (ASV) 
ASV Method 
Anodic Stripping Voltammetry is a highly precise, virtually interference-free method.  
1. Whole blood is added to the reagent solution (Fig. 1),   
2. Any lead present is released from the blood components (Fig. 2).   
3. Now any lead in the reagent solution is concentrated (plated) onto a thin-film electrode 
during the plating step of the analysis cycle (Fig. 3). 
4. The plated lead is removed from the electrode by applying a stripping current (Fig. 4) 
and the  amount of lead is measured by integration of the electrical current released 
during this rapid electrochemical step.   
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Anodic Stripping Voltammetry 
  
 
  
 
  
 
  
 
Figure 1 Figure 2 Figure 3 Figure 4 
The current released during the stripping step, is a directly proportional to the amount of lead 
present in the blood sample. 
Accurate Results 
LeadCare
®
 System vs. Atomic Absorption Spectroscopy performed at a major lead outreach and 
referral clinic/hospital  
   
 Number of Samples  112 
 Slope   1.07 
 Intercept  -0.57 µg/dl 
 Correlation Coefficient   0.97 
 
  
Method Correlation 
Results from the Model 3010B Lead Analyzer have shown close correlation with the widely 
accepted graphite furnace methodologies.  This is further supported by results from numerous 
proficiency surveys. 
 
The Model 3010B provides the sensitivity you need for the detection of blood lead in childhood 
lead screening, industrial hygiene and occupational health monitoring programs. 
 
The LeadCare system operates by fundamentally the same principal but uses a single-use 
electrode contained on a disposable slide. 
 
  
 
